Market Access Consolidating data strategy for global success: Insights fro... At Frontiers Health 2025, Drew McCormick, Head of Data and Analytics at EVERSANA, emphasised a critical truth: data strategy is launch strategy.
Sales & Marketing Unlocking pharma launch potential: Integrated data strategie... Launch teams need real-time, integrated intelligence to navigate tighter markets, faster timelines, and rising expectations.
Sales & Marketing Sponsored Beyond the grid: Rethinking tracking studies for pharma’s ne... As the healthcare landscape continues to evolve rapidly, the tools used to understand it must keep pace.
R&D Reimagining biopharma: How AI is reshaping discovery, develo... No longer confined to experimental pilots, AI is becoming a catalyst for change across the entire biopharma value chain - but there are challenges.
Digital Sponsored Unlocking AI's potential: Transforming healthcare commercial... As the race to deliver personalised engagement at scale gains pace, artificial intelligence (AI) has become a critical differentiator for pharma companies.
Digital Turning pilots into production: How to create, scale, and su... Pharmaceutical companies are eagerly pursuing GenAI products and use cases to generate value within their organisations.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.